RankAlpha logo
Back to Rankings

HIND

VyomeF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
HIND vs peer average
30/100
HIND vs. peer average (F vs. D)
Grade spread
A 1 · C 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CTXR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $16.56M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCTXRCitius
HIND
Vyome
CTXR
Citius
Grade
F
F
Momentum
33
22
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CTXR

HIND / CTXR
Grade Position
Below peers
HIND vs. peer average (F vs. D)
30/100
Momentum
33
HIND
Value
41
HIND
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HIND
1
CTXR
Citius Pharmaceuticals Inc Common
F
20/100
Even
2
AKTX
Akari Therapeutics Plc ADR
D
40/100
-1
3
GTBP
GT Biopharma Inc Common
D
40/100
-1
4
JSPR
Jasper Therapeutics Inc Common
A
100/100
-4
5
INAB
IN8bio Inc Common
D
40/100
-1
CTXR is the first peer returned for this comparison set.